An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Neurology, Miller School of Medicine, University of Miami , Boston, MA , USA ; Massachusetts General Hospital , Boston, MA , USA.
2 Apptomics LLC , Wellesley Hills, MA , USA.
3 James J. and Joan A. Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati Neuroscience Institute , Cincinnati, OH , USA.
1 Department of Neurology, Miller School of Medicine, University of Miami , Boston, MA , USA ; Massachusetts General Hospital , Boston, MA , USA.
2 Apptomics LLC , Wellesley Hills, MA , USA.
3 James J. and Joan A. Gardner Center for Parkinson's Disease and Movement Disorders, University of Cincinnati Neuroscience Institute , Cincinnati, OH , USA.
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology (2007) 68(5):384–610.1212/01.wnl.0000247740.47667.03
-
DOI
-
PubMed
Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord (2013) 28(3):311–8.10.1002/mds.25292
-
DOI
-
PubMed
Fahn S. Description of Parkinson’s disease as a clinical syndrome. Ann N Y Acad Sci (2003) 991:1–1410.1111/j.1749-6632.2003.tb07458.x
-
DOI
-
PubMed
Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol (1999) 56(1):33–910.1001/archneur.56.1.33
-
DOI
-
PubMed
Gallagher DA, Schrag A. Impact of newer pharmacological treatments on quality of life in patients with Parkinson’s disease. CNS Drugs (2008) 22(7):563–86.10.2165/00023210-200822070-00003
-
DOI
-
PubMed